MANUFACTURERS LIFE INSURANCE COMPANY, THE - HERON THERAPEUTICS INC ownership

HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 186 filers reported holding HERON THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.47 and the average weighting 0.6%.

Quarter-by-quarter ownership
MANUFACTURERS LIFE INSURANCE COMPANY, THE ownership history of HERON THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$20,191
-68.0%
19,603
-53.1%
0.00%
Q1 2023$63,052
-39.6%
41,7560.0%0.00%
Q4 2022$104,390
-40.9%
41,756
-0.3%
0.00%
Q3 2022$176,763
+46.8%
41,887
-2.9%
0.00%
Q2 2022$120,386
-46.9%
43,149
+9.0%
0.00%
Q1 2022$226,512
-49.4%
39,600
-19.4%
0.00%
Q4 2021$448,000
-14.3%
49,117
+0.4%
0.00%
Q3 2021$523,000
-35.7%
48,936
-6.6%
0.00%
-100.0%
Q2 2021$813,000
+2.3%
52,415
+6.9%
0.00%0.0%
Q1 2021$795,000
-26.9%
49,038
-4.6%
0.00%0.0%
Q4 2020$1,088,000
+48.2%
51,408
+3.8%
0.00%0.0%
Q3 2020$734,000
+2.1%
49,509
-1.9%
0.00%0.0%
Q2 2020$719,000
+19.0%
50,446
-2.0%
0.00%0.0%
Q1 2020$604,000
-39.7%
51,462
+20.8%
0.00%0.0%
Q4 2019$1,001,000
+15.7%
42,592
-3.5%
0.00%0.0%
Q3 2019$865,000
+5.2%
44,135
-0.2%
0.00%0.0%
Q2 2019$822,000
-22.0%
44,222
+2.5%
0.00%0.0%
Q1 2019$1,054,000
-3.9%
43,129
+2.0%
0.00%0.0%
Q4 2018$1,097,000
-19.4%
42,292
-1.6%
0.00%0.0%
Q3 2018$1,361,000
-22.8%
42,997
-5.3%
0.00%
-50.0%
Q2 2018$1,763,000
+63.8%
45,387
+16.5%
0.00%
+100.0%
Q1 2018$1,076,000
+77.0%
38,968
+15.9%
0.00%0.0%
Q4 2017$608,000
+9.9%
33,619
-1.6%
0.00%0.0%
Q3 2017$553,000
+14.7%
34,178
-1.6%
0.00%0.0%
Q2 2017$482,000
+20.8%
34,741
+30.6%
0.00%0.0%
Q1 2017$399,000
+41.5%
26,606
+23.7%
0.00%
Q4 2016$282,000
-22.3%
21,508
+2.1%
0.00%
-100.0%
Q3 2016$363,000
-4.7%
21,067
-0.2%
0.00%0.0%
Q2 2016$381,000
+6.1%
21,104
+14.0%
0.00%
Q1 2016$359,000
-26.0%
18,519
+2.0%
0.00%
Q4 2015$485,000
+10.7%
18,151
+1.1%
0.00%
Q3 2015$438,000
-6.8%
17,952
+19.0%
0.00%
-100.0%
Q2 2015$470,000
+106.1%
15,087
-3.9%
0.00%
Q1 2015$228,000
+39.9%
15,697
-3.2%
0.00%
Q4 2014$163,000
+23.5%
16,208
+2.3%
0.00%
Q3 2014$132,000
-20.5%
15,846
+17.9%
0.00%
Q2 2014$166,00013,4390.00%
Other shareholders
HERON THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 8,648,252$238,692,00035.08%
Broadfin Capital, LLC 1,581,416$43,647,0006.80%
Tavio Capital LLC 351,729$9,708,0004.58%
Mesirow Financial Investment Management, Inc. 33,389$922,0003.88%
Rubric Capital Management LP 1,510,008$41,676,0003.88%
KINGDON CAPITAL MANAGEMENT, L.L.C. 1,666,229$45,988,0003.63%
First Light Asset Management, LLC 473,275$13,062,0002.87%
Asymmetry Capital Management, L.P. 77,346$2,135,0002.67%
Copernicus Capital Management, LLC 108,000$2,981,0002.38%
BRIDGER MANAGEMENT, LLC 1,277,560$35,261,0002.14%
View complete list of HERON THERAPEUTICS INC shareholders